Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2017 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2017 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway

  • Authors:
    • Bohui Liu
    • Suping Zhang
    • Xifeng Xiong
    • Li Ling
    • Rui He
    • Muzhen Wang
    • Wanqing Deng
    • Zhihe Liu
    • Yi Li
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, Guangdong 510220, P.R. China, Guangzhou Institute of Traumatic Surgery, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, Guangdong 510220, P.R. China
    Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3117-3124
    |
    Published online on: July 14, 2017
       https://doi.org/10.3892/mmr.2017.6984
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The pathological mechanism of vascular cognitive impairment (VCI) involves ischemic lesions in the hippocampus. Prostaglandin E1 (PGE1) serves roles in the promotion of vascular endothelial growth factor (VEGF) expression, angiogenesis and enhances blood flow to ischemic regions. However, the effect of PGE1 on cognitive function in VCI rats and the underlying mechanism are unknown. In the current study, learning and memory function in VCI rats treated by lipo‑PGE1 injection was assessed through Morris Water Maze test. Furthermore, the histological alterations, blood vessel numbers in the hippocampal CA1 region and relative VEGF protein and mRNA expression were researched. The results confirmed that VCI rats treated with lipo‑PGE1 presented improved cognitive function, less neuronal cell loss, a greater number of blood vessels in the hippocampal region and higher VEGF protein and mRNA expression. However, the role of lipo‑PGE1 in VCI rats can be inhibited by SU5416 (a specific VEGFR2 antagonist). The results indicated that lipo‑PGE1 may alleviate cognitive deficits in VCI rats. The underlying mechanism may be associated with angiogenesis promoted by lipo‑PGE1, which may involve the VEGF/VEGFR pathway. These findings may have therapeutic implications for cognitive impairment induced by hypoperfusion or chronic ischemic lesions.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, Lobo A, Martinez-Lage J, Soininen H and Hofman A: Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 54:(11 Suppl 5). S10–S15. 2000.PubMed/NCBI

2 

Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, Middleton L, Russ TC, Deary IJ, Campbell H, et al: Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: A systematic review and analysis. Lancet. 381:2016–2023. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Østergaard L, Engedal TS, Moreton F, Hansen MB, Wardlaw JM, Dalkara T, Markus HS and Muir KW: Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline. J Cereb Blood Flow Metab. 36:302–325. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Liu H and Zhang J: Cerebral hypoperfusion and cognitive impairment: The pathogenic role of vascular oxidative stress. Int J Neurosci. 122:494–499. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Helman AM and Murphy MP: Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. Biochim Biophys Acta. 1862:975–982. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Lu H, Wang Y, He X, Yuan F, Lin X, Xie B, Tang G, Huang J, Tang Y, Jin K, et al: Netrin-1 hyperexpression in mouse brain promotes angiogenesis and long-term neurological recovery after transient focal ischemia. Stroke. 43:838–843. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, Kucinski T, Jungehülsing GJ, Brunecker P, Müller B, et al: Transient ischemic attacks before ischemic stroke: Preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke. 35:616–621. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH and Hermann DM: The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 20:1185–1187. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Ferrara N: Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev. 25:581–611. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Schror K and Hohlfeld T: Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease. Vasa. 33:119–124. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Fang W, Li H, Zhou L, Su L, Liang Y and Mu Y: Effect of prostaglandin E1 on TNF-induced vascular inflammation in human umbilical vein endothelial cells. Can J Physiol Pharmacol. 88:576–583. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Tang J, Hua Y, Su J, Zhang P, Zhu X, Wu L, Niu Q, Xiao H and Ding X: Expression of VEGF and neural repair after alprostadil treatment in a rat model of sciatic nerve crush injury. Neurol India. 57:387–394. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Ling L, Zhang S, Ji Z, Huang H, Yao G, Wang M, He R, Deng W and Fang L: Therapeutic effects of lipo-prostaglandin E1 on angiogenesis and neurogenesis after ischemic stroke in rats. Int J Neurosci. 126:469–477. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Inoue H, Aihara M, Tomioka M and Watabe Y: Specific enhancement of vascular endothelial growth factor (VEGF) production in ischemic region by alprostadil-potential therapeutic application in pharmaceutical regenerative medicine. J Pharmacol Sci. 122:158–161. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Zhang ZH, Shi GX, Li QQ, Wang YJ, Li P, Zhao JX, Yang JW and Liu CZ: Comparison of cognitive performance between two rat models of vascular dementia. Int J Neurosci. 124:818–823. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Paxinos G and Franklin K: Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates4th. Academic Press; San Diego, CA: 2001

17 

Fujita Y, Ihara M, Ushiki T, Hirai H, Kizaka-Kondoh S, Hiraoka M, Ito H and Takahashi R: Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow. Stroke. 41:2938–2943. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Xie W, Zhu D, Ji L, Tian M, Xu C and Shi J: Angiotensin-(1–7) improves cognitive function in rats with chronic cerebral hypoperfusion. Brain Res. 1573:44–53. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Ma C, Wu G, Wang Z, Wang P, Wu L, Zhu G and Zhao H: Effects of chronic sleep deprivation on the extracellular signal-regulated kinase pathway in the temporomandibular joint of rats. PLoS One. 9:e1075442014. View Article : Google Scholar : PubMed/NCBI

21 

García PL Rodríguez and García D Rodríguez: Diagnosis of vascular cognitive impairment and its main categories. Neurologia. 30:223–239. 2015.(In English, Spanish). PubMed/NCBI

22 

Henke K: A model for memory systems based on processing modes rather than consciousness. Nat Rev Neurosci. 11:523–532. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Chen H, Iinuma M, Onozuka M and Kubo KY: Chewing maintains hippocampus-dependent cognitive function. Int J Med Sci. 12:502–509. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Jiwa NS, Garrard P and Hainsworth AH: Experimental models of vascular dementia and vascular cognitive impairment: A systematic review. J Neurochem. 115:814–828. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Miki K, Ishibashi S, Sun L, Xu H, Ohashi W, Kuroiwa T and Mizusawa H: Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice. J Neurosci Res. 87:1270–1281. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Buzsáki G and Moser EI: Memory, navigation and theta rhythm in the hippocampal-entorhinal system. Nat Neurosci. 16:130–138. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Liu HX, Zhang JJ, Zheng P and Zhang Y: Altered expression of MAP-2, GAP-43, and synaptophysin in the hippocampus of rats with chronic cerebral hypoperfusion correlates with cognitive impairment. Brain Res Mol Brain Res. 139:169–177. 2005. View Article : Google Scholar : PubMed/NCBI

28 

Xi Y, Wang M, Zhang W, Bai M, Du Y, Zhang Z, Li Z and Miao J: Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion. Neurobiol Learn Mem. 109:7–19. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Qu J, Zhou Q, Du Y, Zhang W, Bai M, Zhang Z, Xi Y, Li Z and Miao J: Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion. Br J Pharmacol. 171:3702–3715. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Wang J, Zhang HY and Tang XC: Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. J Neurosci Res. 88:807–815. 2010.PubMed/NCBI

31 

Slevin M, Kumar P, Gaffney J, Kumar S and Krupinski J: Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci (Lond). 111:171–183. 2006. View Article : Google Scholar : PubMed/NCBI

32 

Cao M, Ke K, Sun H and Robertson A: Effects of prostaglandin E1 on perihematomal tissue after hypertensive intracerebral hemorrhage. Acta Neurol Taiwan. 20:172–181. 2011.PubMed/NCBI

33 

Sheng R, Zhang LS, Han R, Gao B, Liu XQ and Qin ZH: Combined prostaglandin E1 and lithium exert potent neuroprotection in a rat model of cerebral ischemia. Acta pharmacol Sin. 32:303–310. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Keskin U, Totan Y, Karadağ R, Erdurmuş M and Aydin B: Inhibitory effects of SU5416, a selective vascular endothelial growth factor receptor tyrosine kinase inhibitor, on experimental corneal neovascularization. Ophthalmic Res. 47:13–18. 2012. View Article : Google Scholar : PubMed/NCBI

35 

Webber MJ, Tongers J, Newcomb CJ, Marquardt KT, Bauersachs J, Losordo DW and Stupp SI: Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci USA. 108:13438–13443. 2011. View Article : Google Scholar : PubMed/NCBI

36 

Zacchigna S, Lambrechts D and Carmeliet P: Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci. 9:169–181. 2008. View Article : Google Scholar : PubMed/NCBI

37 

Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, et al: Treatment of motoneuron degeneration by intracerebroventriculsar delivery of VEGF in a rat model of ALS. Nat Neurosci. 8:85–92. 2005. View Article : Google Scholar : PubMed/NCBI

38 

Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D and During MJ: VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet. 36:827–835. 2004. View Article : Google Scholar : PubMed/NCBI

39 

Schänzer A, Wachs FP, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H, Winkler J, Aigner L, Plate KH and Kuhn HG: Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol. 14:237–248. 2004. View Article : Google Scholar : PubMed/NCBI

40 

Carmeliet P: Blood vessels and nerves: Common signals, pathways and diseases. Nat Rev Genet. 4:710–720. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu B, Zhang S, Xiong X, Ling L, He R, Wang M, Deng W, Liu Z and Li Y: Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway. Mol Med Rep 16: 3117-3124, 2017.
APA
Liu, B., Zhang, S., Xiong, X., Ling, L., He, R., Wang, M. ... Li, Y. (2017). Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway. Molecular Medicine Reports, 16, 3117-3124. https://doi.org/10.3892/mmr.2017.6984
MLA
Liu, B., Zhang, S., Xiong, X., Ling, L., He, R., Wang, M., Deng, W., Liu, Z., Li, Y."Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway". Molecular Medicine Reports 16.3 (2017): 3117-3124.
Chicago
Liu, B., Zhang, S., Xiong, X., Ling, L., He, R., Wang, M., Deng, W., Liu, Z., Li, Y."Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway". Molecular Medicine Reports 16, no. 3 (2017): 3117-3124. https://doi.org/10.3892/mmr.2017.6984
Copy and paste a formatted citation
x
Spandidos Publications style
Liu B, Zhang S, Xiong X, Ling L, He R, Wang M, Deng W, Liu Z and Li Y: Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway. Mol Med Rep 16: 3117-3124, 2017.
APA
Liu, B., Zhang, S., Xiong, X., Ling, L., He, R., Wang, M. ... Li, Y. (2017). Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway. Molecular Medicine Reports, 16, 3117-3124. https://doi.org/10.3892/mmr.2017.6984
MLA
Liu, B., Zhang, S., Xiong, X., Ling, L., He, R., Wang, M., Deng, W., Liu, Z., Li, Y."Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway". Molecular Medicine Reports 16.3 (2017): 3117-3124.
Chicago
Liu, B., Zhang, S., Xiong, X., Ling, L., He, R., Wang, M., Deng, W., Liu, Z., Li, Y."Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway". Molecular Medicine Reports 16, no. 3 (2017): 3117-3124. https://doi.org/10.3892/mmr.2017.6984
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team